Literature DB >> 11425775

Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice.

P J Kuhlencordt1, J Chen, F Han, J Astern, P L Huang.   

Abstract

BACKGROUND: Inducible nitric oxide synthase (iNOS) is expressed by leukocytes and smooth muscle cells in atherosclerotic lesions. To test whether NO produced by iNOS deficiency affects atherosclerosis, we studied apoE/iNOS-double knockout (dKO) and apoE-knockout (KO) control animals fed a "Western-type" diet. METHODS AND
RESULTS: After 16 weeks of Western-type diet, the aortic lesion area in apoE/iNOS-dKO males and females was significantly reduced, by 22% and 21%, respectively, compared with apoE-KO males and females. This effect was more pronounced after 24 weeks of Western-type diet, after which lesion formation in male and female dKO mice was reduced by 38% and 40%, respectively. Plasma levels of lipoperoxides in apoE/iNOS-dKO mice (2.0+/-0.23 micromol/L) were significantly lower than in apoE-KO control animals (3.2+/-0.44 micromol/L; P=0.02). To test whether substrate deficiency plays a role in the proatherogenic actions of iNOS, we administered L-arginine to apoE-KO animals for 16 and 24 weeks. L-Arginine treatment did not affect lesion formation in apoE-KO animals fed a Western-type diet.
CONCLUSIONS: Genetic deficiency of iNOS decreases diet-induced atherosclerosis and lowers plasma levels of lipoperoxides, a marker for oxidative stress, in apoE-KO animals. Reduction in iNOS-mediated oxidative stress could partly explain protection from lesion formation in dKO animals. L-Arginine supplementation did not change lesion area in apoE-KO mice, indicating that substrate deficiency is not a likely cause for iNOS-mediated injury in this model of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11425775     DOI: 10.1161/01.cir.103.25.3099

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  74 in total

Review 1.  Nitric oxide synthases in the pathogenesis of cardiovascular disease: lessons from genetically modified mice.

Authors:  Hiroaki Shimokawa; Masato Tsutsui
Journal:  Pflugers Arch       Date:  2010-02-24       Impact factor: 3.657

2.  Mechanisms related to NO-induced motility in differentiated rat aortic smooth muscle cells.

Authors:  Qinghua Pu; Daming Zhuang; Shalini Thakran; Aviv Hassid
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-29       Impact factor: 4.733

Review 3.  Polymorphisms in endothelial nitric oxide synthase and carotid artery atherosclerosis.

Authors:  Claudio Napoli; Louis J Ignarro
Journal:  J Clin Pathol       Date:  2006-07-12       Impact factor: 3.411

4.  Induction of inducible NO synthase in bystander human T cells increases allogeneic responses in the vasculature.

Authors:  Jonathan C Choy; Yinong Wang; George Tellides; Jordan S Pober
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-16       Impact factor: 11.205

5.  Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice.

Authors:  Masanori Ozaki; Seinosuke Kawashima; Tomoya Yamashita; Tetsuaki Hirase; Masayuki Namiki; Nobutaka Inoue; Ken-ichi Hirata; Hiroyuki Yasui; Hiromu Sakurai; Yuichi Yoshida; Masahiro Masada; Mitsuhiro Yokoyama
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

Review 6.  Endothelial nitric oxide synthase and endothelial dysfunction.

Authors:  Paul L Huang
Journal:  Curr Hypertens Rep       Date:  2003-12       Impact factor: 5.369

7.  A proatherogenic role for cGMP-dependent protein kinase in vascular smooth muscle cells.

Authors:  Wiebke Wolfsgruber; Susanne Feil; Sabine Brummer; Oliver Kuppinger; Franz Hofmann; Robert Feil
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

8.  Apolipoprotein E inhibition of vascular hyperplasia and neointima formation requires inducible nitric oxide synthase.

Authors:  Zachary W Q Moore; David Y Hui
Journal:  J Lipid Res       Date:  2005-08-01       Impact factor: 5.922

Review 9.  Redox signaling in cardiovascular health and disease.

Authors:  Nageswara R Madamanchi; Marschall S Runge
Journal:  Free Radic Biol Med       Date:  2013-04-11       Impact factor: 7.376

10.  The Relationship of Serum Soluble Fas Ligand (sFasL) Level with the Extent of Coronary Artery Disease.

Authors:  Asife Sahinarslan; Bulent Boyaci; Sinan Altan Kocaman; Salih Topal; Ugur Ercin; Kaan Okyay; Neslihan Bukan; Ridvan Yalçin; Atiye Cengel
Journal:  Int J Angiol       Date:  2012-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.